Oil war: Reemergence of American Shale Oil Boom Destroying
Oil war: Reemergence of American Shale Oil Boom Destroying Saudi Arabia
Fitch Credit Ratings has declared that the profitable doubling of U.S. oil drilling over the last 9 months means the reemerging U.S. shale boom is a potent threat to Saudi Arabia — despite the Saudis declaring a price war in 2014.
According to the Fitch report released on March 7, “The recovery in US drilling activity will drive up shale oil production in the second half of 2017, offsetting a portion of recent oil price gains.” The rating agency’s comment follows an effort by Saudi Arabia that began in October 2014 to drive the price of oil down from over $100 a barrel in an effort to kill the U.S. shale boom.
Fitch cited the Baker Hughes U.S. crude oil drilling rig count that fell last year to 316 for the week ending on May 27, the lowest level since the 1940s, but has since jumped 93 percent to 609 on March 3. Fitch said that due to booming U.S. production, “We therefore expect average oil prices for the year to be below those in January and February.”
Breitbart News reported that Saudi Arabia was a prime beneficiary from the 1998 to 2014 commodity “supercycle” that saw the oil price rise by 1,062 percent to a high of $116 a barrel. The resulting tsunami of cash flow allowed the nation of 31 million, where only 5.5 million have jobs, to accumulate $737 billion in foreign exchange reserves, while fully subsidizing a Western upper-middle-class lifestyle for the population.
Despite Saudi Arabia needing a price of $90 per barrel to fund its lavish domestic entitlements, the kingdom in mid-2014 spiked production by 2 million barrels a day to destroy the U.S. oil fracking industry — which, based on a $90 a barrel breakeven cost, had more than doubled U.S. crude oil production to 9.3 million barrels a day.
According to George Friedman of Geopolitical Futures, the price war cost Saudi Arabia at least $198 billion though January 2017, and created a worldwide surplus that drove the price oil down to an 18-year low of $23 a barrel in January 2016. Even after modest production cutbacks since then, the price only partially recovered, to about $53.18 a barrel.
The Saudi predatory attack caused a large number of bankruptcies across the U.S. oil patch and sent U.S. crude oil production skidding to 8.4 million barrels a day by mid-2016. But instead of the American shale boom going bust, the U.S. Energy Information Agency reported that domestic crude oil production hit just 9.1 million barrel a day.
Peter Zeihan, in his new book The Absent Superpower, reveals that a combination of 40 percent cost-cutting, plus technological advances that quadrupled the amount of oil recovered from each well drilled, have together slashed the breakeven cost in the four largest “shale fracking plays” to about $40 a barrel. He predicts that the breakeven could drop to $25 a barrel by 2019, making U.S. shale producers the lowest cost oil producers on the planet.
With oil trading in the $50 range, and Saudi Arabia still running a multi-billion dollar monthly deficit, Geopolitical Futures reported that King Salman Bin Abdulaziz announced that the Saudi Aramco state-owned oil monopoly will go public in 2018.
With what Geopolitical Futures refers to as harsh economic realities of negative cash flow hammering Saudi Arabia’s solvency, King Salman has been forced to go, keffiyeh in hand (along with a 1,500-strong entourage and 908,000 lbs. of luggage), on a six-nation Asian tour that includes stops in Malaysia, Brunei, Maldives, Indonesia, China, and Japan to try drum up demand for the price of Saudi Aramco shares.
The world standard Brent Crude Oil price fell $2.81, or 5 percent, to $53.11 a barrel on the London ICE Futures Europe Exchange on March 8, its lowest close since Dec. 7.
< >
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Innovating Financial Analysis with AI They said AI would change everything, but who knew it'd make such a wave in turning research ideas into actionable datasets? RavenPack's latest maneuver is rewriting the playbook. By leveraging a fine-tuned NVIDIA Nemotron model, they've managed to label a mind-boggling 845,220 financial-text excerpts in under an hour. It's not just...
Continue Reading
In a world where medical tech innovation can make the difference between life and death, Sony’s latest feat will turn some heads in the healthcare industry. This ain’t about another PlayStation release; we’re talking the IMX742 CMOS image sensor crafted for single-use endoscopes. As far as breakthroughs go, the microscopic square sensor packs a surprising punch by...
Continue Reading
Sony's Bold Move into Medical Tech You wouldn't expect a company like Sony to make waves in the medical field, but there they go again, shaking things up with their latest announcement. Lurking past the shiny consumer electronics, they've got the IMX742, a sensor designed for single-use endoscopes. A humble 1 mm square powerhouse, boasting about 0.51 megapixels of digital...
Continue Reading
Big Ambitions Nestled in Milford, Ohio Beneath the glow of fluorescent lights in a fresh-to-the-world 12,000-square-foot box of opportunity, EverSmith Brands is betting on big returns. EverHUB has opened its doors, aiming to be the cradle that hatches their aggressive franchise dreams into reality. It's not just brick and mortar—it’s the manifestation of their grand...
Continue Reading
Trilogy Metals Completes Ambler Metals Field Work Alright, folks, let's dive into a mining story that should catch the discerning eye. Trilogy Metals (NYSE: TMQ) proudly wrapped up its 2026 field season at the Upper Kobuk Mineral Projects (UKMP), located in northwestern Alaska. And if you're neck-deep in the mining sector, this isn't just a thing on the periphery; it's a...
Continue Reading
High Stakes for Chemours Shareholders Well, this isn’t your run-of-the-mill shareholder grumble. We're staring down an 18.63% plunge in Chemours’ stock—plenty to raise the eyebrows of anyone keeping tabs on this chemical giant. For those who snatched up Chemours shares between February 20 and August 4, 2026, the revelations about potential misstatements concerning...
Continue Reading
You know, sometimes it feels like the financial world gets more tangled than a fishing line on a windy beach. This latest spiel coming out of St. Croix with all its big names and lofty promises—Governor Bryan’s 3rd Wall Street Financial District Hub Initiative—seems like one of those, but maybe it’s got more meat than hype. Half the pitch sounds like your typical...
Continue Reading
Diversifying with Property Restoration Stroll through any franchise expo and the buzzwords are all there: growth, opportunity, scalability. But in the crowded room of glittery pitches, the ones really shaking things up are those that go beyond the razzle-dazzle—brands like PuroClean that stick it to the competition with real, boots-on-the-ground expansion. The...
Continue Reading
In the fast-paced world of executive advising, Pearl Meyer just cranked up the heat, announcing the addition of four seasoned managing directors to their Leadership Advisory practice. These new folks are here to shake things up, with a strong focus on executive assessment, leadership effectiveness, and organizational transformation. Strategic Moves in Leadership Adding...
Continue Reading
MIAX Sets Sights on Fertilizer Futures Out of the blue, we’ve got MIAX—one of the major players in financial markets—tossing their hat into the ring with fertilizer futures. They aren’t just playing around; they’ve launched four new physically-settled fertilizer futures contracts. You might wonder, why fertilizers? Hang tight, I'll tell you. MIAX is tapping into...
Continue Reading
Top 5 Most Recently Viewed Articles
Traws Pharma Unveils Encouraging Results for Tivoxavir Marboxil In a significant advancement for viral therapies, Traws Pharma, Inc. (NASDAQ: TRAW) has reported promising Phase 1 clinical trial results regarding its innovative flu treatment, tivoxavir marboxil. This investigational drug aims to revolutionize how influenza, particularly the seasonal and pandemic types, is...
Continue Reading
VdoCipher's Effective Piracy Detection Technology In an era where digital content is king, the security of premium videos has become an essential priority. Streaming platforms have revolutionized access to content, yet this accessibility has inadvertently led to rampant piracy. VdoCipher, a secure video hosting solution, is stepping up to this challenge with remarkable...
Continue Reading
Arcosa Inc. (NYSE: ACA) hit a record stock price of $95.67, marking a notable milestone in its growth trajectory with a whopping 26.38% surge over the past year. This uptick doesn't just reflect solid investor confidence; it also indicates how well Arcosa is positioning itself in the market, riding waves of robust demand across various business segments. Stock Surge:...
Continue Reading
Lightspeed and 7shifts Partnership Overview In an exciting development for the restaurant industry, Lightspeed Commerce Inc. has expanded its partnership with 7shifts, a leader in workforce management for restaurants. This collaboration aims to enhance payroll processing and operational efficiency for establishments across North America. Together, they are set to...
Continue Reading
Brian Callanan Joins Flagstar Financial's Board of Directors Flagstar Financial, Inc. (NYSE: FLG) has announced a significant addition to its Board of Directors with the appointment of Brian Callanan as a new member. This decision marks an important step as the company focuses on its long-term vision and growth strategy. Expertise in Financial Services Brian Callanan...
Continue Reading